Rapport Therapeutics Inc (RAPP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -76,472 | -19,857 | -111,483 | -77,720 | -50,795 |
| Depreciation Amortization | 420 | -137 | -379 | 428 | -32 |
| Accounts receivable | -293 | -58 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -1,374 | 2,305 | 2,215 | 1,037 | 1,216 |
| Other Working Capital | 6,042 | -765 | 3,502 | -105 | -3,803 |
| Other Operating Activity | 17,161 | 5,451 | 18,672 | 13,588 | 8,107 |
| Operating Cash Flow | $-54,516 | $-13,061 | $-87,473 | $-62,772 | $-45,307 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 63,512 | 38,027 | -186,857 | -12,702 | 43,940 |
| PPE Investments | 29 | -86 | -616 | -447 | -313 |
| Investing Cash Flow | $63,541 | $37,941 | $-187,473 | $-13,149 | $43,627 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,401 | 809 | 270,787 | 270,476 | 6 |
| Common Stock Repurchased | -5 | -5 | -1 | -1 | -1 |
| Other Financing Activity | -454 | -273 | 0 | 0 | -63 |
| Financing Cash Flow | $1,942 | $531 | $270,786 | $270,475 | $-58 |
| Beginning Cash Position | 52,750 | 52,750 | 56,910 | 56,910 | 56,910 |
| End Cash Position | 63,717 | 78,161 | 52,750 | 251,464 | 55,172 |
| Net Cash Flow | $10,967 | $25,411 | $-4,160 | $194,554 | $-1,738 |
| Free Cash Flow | |||||
| Operating Cash Flow | -54,516 | -13,061 | -87,473 | -62,772 | -45,307 |
| Capital Expenditure | -164 | -86 | -616 | -447 | -313 |
| Free Cash Flow | -54,680 | -13,147 | -88,089 | -63,219 | -45,620 |